Adial Pharmaceuticals
Stock Forecast, Prediction & Price Target

Adial Pharmaceuticals Financial Estimates

Adial Pharmaceuticals Revenue Estimates

Adial Pharmaceuticals EBITDA Estimates

Adial Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $23.19M
Low: $23.19M
High: $23.19M
avg. 0%
Avg: $46M
Low: $46M
High: $46M
avg. 98.36%
Avg: $94M
Low: $94M
High: $94M
avg. 104.34%
Avg: $34.39M
Low: $34.39M
High: $34.39M
avg. -63.41%
Net Income
 
% change YoY
$-19.42M
 
N/A
$-12.73M
 
34.45%
$-7.00M
 
45.00%
Avg: $-10.14M
Low: $-2.73M
High: $-2.15M
avg. -44.81%
Avg: $-17.85M
Low: $-2.49M
High: $-2.49M
avg. -76.09%
Avg: $-1.15M
Low: $-1.15M
High: $-1.15M
avg. 93.53%
Avg: $-28.49K
Low: $-28.49K
High: $-28.49K
avg. 97.53%
EBITDA
 
% change YoY
$-15.85M
 
N/A
$-13.77M
 
13.09%
$-7.00M
 
49.18%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$26.12
 
N/A
-$317.81
 
-1116.73%
-$5.44
 
98.28%
Avg: -$1.72
Low: -$1.92
High: -$1.51
avg. 68.47%
Avg: -$1.75
Low: -$1.75
High: -$1.75
avg. -2.04%
Avg: -$0.81
Low: -$0.81
High: -$0.81
avg. 53.71%
Avg: -$0.02
Low: -$0.02
High: -$0.02
avg. 97.53%
Operating Expenses
 
% change YoY
$17.74M
 
N/A
$13.31M
 
-24.93%
$6.88M
 
-48.27%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Adial Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 17.53% in 2025-2028.

We have gathered data from 1 analysts. Their low estimate is -2.73M, average is -10.14M and high is -2.15M.

What is Adial Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 34.82% in 2025-2028.

We have gathered data from 2 analysts. Their low revenue estimate is $23.19M, average is $23.19M and high is $23.19M.

What is Adial Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 54.41% in 2025-2028.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.92, average is -$1.72 and high is $-1.51.